Label: MASTIKIS QINGXIN CARE MASTIC- silicon dioxide, tocopherol acetate, tetrasodium pyrophosphate paste, dentifrice
-
Contains inactivated NDC Code(s)
NDC Code(s): 79814-006-01, 79814-006-02 - Packager: Mastic Korea.Co.Ltd
- Category: HUMAN OTC DRUG LABEL
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 21, 2020
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
-
INACTIVE INGREDIENT
D-Sorbitol Solution, Glycerin, Polyethylene Glycol1500, Trisodium Citrate, Carboxymethylcellulose Sodium, Bamboo salt, Xylitol, Steviol Glycoside, Bioactive Herb Complex-C(BHC-C), Allura Red AC, L-Menthol, Grapefruit Seed Extract, Mastic oil, Rose Extract, Propolis Extract, Aloe Extract, Eucalyptus Oil, Sodium Lauroyl Sarcosinate, Sodium Cocoyl Glutamate, Deionized Water
- KEEP OUT OF REACH OF CHILDREN
- PURPOSE
- WARNINGS
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
MASTIKIS QINGXIN CARE MASTIC
silicon dioxide, tocopherol acetate, tetrasodium pyrophosphate paste, dentifriceProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:79814-006 Route of Administration DENTAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (SILICON DIOXIDE - UNII:ETJ7Z6XBU4) SILICON DIOXIDE 14 g in 100 g .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) (.ALPHA.-TOCOPHEROL - UNII:H4N855PNZ1) .ALPHA.-TOCOPHEROL ACETATE 0.1 g in 100 g SODIUM PYROPHOSPHATE (UNII: O352864B8Z) (PYROPHOSPHORIC ACID - UNII:4E862E7GRQ) SODIUM PYROPHOSPHATE 0.5 g in 100 g Inactive Ingredients Ingredient Name Strength SORBITOL (UNII: 506T60A25R) GLYCERIN (UNII: PDC6A3C0OX) POLYETHYLENE GLYCOL 1600 (UNII: 1212Z7S33A) SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR) CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311) XYLITOL (UNII: VCQ006KQ1E) STEVIOSIDE (UNII: 0YON5MXJ9P) FD&C RED NO. 40 (UNII: WZB9127XOA) LEVOMENTHOL (UNII: BZ1R15MTK7) CITRUS PARADISI SEED (UNII: 12F08874Y7) PROPOLIS WAX (UNII: 6Y8XYV2NOF) ALOE (UNII: V5VD430YW9) EUCALYPTUS OIL (UNII: 2R04ONI662) SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618) SODIUM COCOYL GLUTAMATE (UNII: BMT4RCZ3HG) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:79814-006-02 1 in 1 CARTON 09/21/2020 1 NDC:79814-006-01 120 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 09/21/2020 Labeler - Mastic Korea.Co.Ltd (687791189) Registrant - Mastic Korea.Co.Ltd (687791189) Establishment Name Address ID/FEI Business Operations Sungwon Pharmaceutical Co., Ltd. 689787898 manufacture(79814-006)